Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2001-3-15
pubmed:abstractText
Prekallikrein (PK) activation on human umbilical endothelial cells (HUVEC) presumably leads to bradykinin liberation. On HUVEC, PK activation requires the presence of cell-bound high-molecular-weight kininogen (HK) and Zn(2+). We examined the Zn(2+) requirement for HK binding to and the consequences of PK activation on endothelial cells. Optimal HK binding (14 pmol/10(6) HUVEC) is seen with no added Zn(2+) in HEPES-Tyrode buffer containing gelatin versus 16--32 microM added Zn(2+) in the same buffer containing bovine serum albumin. The affinity and number of HK binding sites on HUVEC are a dissociation constant of 9.6 +/- 1.8 nM and a maximal binding of 1.08 +/- 0.26 x 10(7) sites/cell (means +/- SD). PK is activated to kallikrein by an antipain-sensitive mechanism in the presence of HK and Zn(2+) on HUVEC, human microvascular endothelial cells, umbilical artery smooth muscle cells, and bovine pulmonary artery endothelial cells. Simultaneous with kallikrein formation, bradykinin (5.0 or 10.3 pmol/10(6) HUVEC in the absence or presence of lisinopril, respectively) is liberated from cell-bound HK. Liberated bradykinin stimulates the endothelial cell bradykinin B2 receptor to form nitric oxide. Assembly and activation of PK on endothelial cells modulates their physiological activities.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antipain, http://linkedlifedata.com/resource/pubmed/chemical/Bradykinin, http://linkedlifedata.com/resource/pubmed/chemical/Kallikreins, http://linkedlifedata.com/resource/pubmed/chemical/Kininogen, High-Molecular-Weight, http://linkedlifedata.com/resource/pubmed/chemical/Lisinopril, http://linkedlifedata.com/resource/pubmed/chemical/NG-Nitroarginine Methyl Ester, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Prekallikrein, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Bradykinin, http://linkedlifedata.com/resource/pubmed/chemical/Serum Albumin, Bovine, http://linkedlifedata.com/resource/pubmed/chemical/Zinc, http://linkedlifedata.com/resource/pubmed/chemical/omega-N-Methylarginine
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0363-6135
pubmed:author
pubmed:issnType
Print
pubmed:volume
280
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
H1821-9
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11247797-Animals, pubmed-meshheading:11247797-Antipain, pubmed-meshheading:11247797-Binding Sites, pubmed-meshheading:11247797-Biotinylation, pubmed-meshheading:11247797-Bradykinin, pubmed-meshheading:11247797-Cattle, pubmed-meshheading:11247797-Cells, Cultured, pubmed-meshheading:11247797-Endothelium, Vascular, pubmed-meshheading:11247797-Enzyme Activation, pubmed-meshheading:11247797-Humans, pubmed-meshheading:11247797-Kallikreins, pubmed-meshheading:11247797-Kinetics, pubmed-meshheading:11247797-Kininogen, High-Molecular-Weight, pubmed-meshheading:11247797-Lisinopril, pubmed-meshheading:11247797-Microcirculation, pubmed-meshheading:11247797-NG-Nitroarginine Methyl Ester, pubmed-meshheading:11247797-Nitric Oxide, pubmed-meshheading:11247797-Prekallikrein, pubmed-meshheading:11247797-Pulmonary Artery, pubmed-meshheading:11247797-Receptors, Bradykinin, pubmed-meshheading:11247797-Serum Albumin, Bovine, pubmed-meshheading:11247797-Umbilical Arteries, pubmed-meshheading:11247797-Umbilical Veins, pubmed-meshheading:11247797-Zinc, pubmed-meshheading:11247797-omega-N-Methylarginine
pubmed:year
2001
pubmed:articleTitle
Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation.
pubmed:affiliation
Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109-5669, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.